ResMed (RMD) financials
ResMed revenue and earnings by year
ResMed's revenue was $5.65 billion in the fiscal year to June 30, 2026, up 9.9% from the year before. Net income was $1.52 billion, 26.9% of revenue. Since the fiscal year to June 30, 2017, revenue has grown 11.8% a year on average.
Fiscal years, each labelled by the calendar year it ended in.
Income statement, the last 10 fiscal years
| Fiscal year to | Jun 2026 | Jun 2025 | Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 | Jun 2020 | Jun 2019 | Jun 2018 | Jun 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 5.65 | 5.15 | 4.69 | 4.22 | 3.58 | 3.20 | 2.96 | 2.61 | 2.34 | 2.07 |
| Revenue growth | 9.9% | 9.8% | 10.9% | 18.0% | 11.9% | 8.1% | 13.4% | 11.4% | 13.2% | — |
| Gross profit | 3.45 | 3.05 | 2.66 | 2.36 | 2.02 | 1.84 | 1.72 | 1.49 | 1.33 | 1.20 |
| Gross margin | 61.1% | 59.4% | 56.7% | 55.8% | 56.6% | 57.5% | 58.1% | 57.3% | 57.0% | 58.1% |
| Operating income | 1.89 | 1.69 | 1.32 | 1.13 | 1.00 | 0.90 | 0.81 | 0.58 | 0.54 | 0.43 |
| Operating margin | 33.4% | 32.7% | 28.2% | 26.8% | 28.0% | 28.3% | 27.4% | 22.2% | 23.2% | 20.6% |
| Net income | 1.52 | 1.40 | 1.02 | 0.90 | 0.78 | 0.47 | 0.62 | 0.40 | 0.32 | 0.34 |
| Net margin | 26.9% | 27.2% | 21.8% | 21.3% | 21.8% | 14.8% | 21.0% | 15.5% | 13.5% | 16.6% |
| Diluted EPS | $10.43 | $9.51 | $6.92 | $6.09 | $5.30 | $3.24 | $4.27 | $2.80 | $2.19 | $2.40 |
| Free cash flow | 1.65 | 1.66 | 1.30 | 0.57 | 0.22 | 0.63 | 0.71 | 0.39 | 0.44 | 0.35 |
Diluted EPS is stated in today's shares (adjusted for every split since). Quarterly statements and the income statement as a flow chart are in the app: open RMD in Markets.
How ResMed makes money
Revenue by segment in the quarter to September 30, 2026, as the company reports it.
| Segment | Revenue | Share |
|---|---|---|
| Sleep & Breathing Health | $1.26B | 89.0% |
| Residential Care Software | $155M | 11.0% |
See also: RMD valuation and P/E history · RMD returns
No forecast, no recommendation. This page describes ResMed from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.